InsidersTradesSigma
Follow the HEM파마 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HEM파마 has recorded 30 insider filings. Market capitalisation: €289.6bn. The latest transaction was reported on 13 July 2026 (Purchase). Among the most active insiders: 지요셉. All data is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Fundamental score
Ranked 28,395 of 29,062 companies
10.7
score / 100
Value19
Quality3
FCF yld-6.5%
Earn yld-8.5%
EV/EBITDA·
ROE-194%
Gross mgn4.9%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations30 total
Other
Other
25 of 30 declarations
关于 HEM파마
HEM파마 是一家在 XKRX 市场上市的健康和制药公司。它专注于药品开发和分销。